InvestorsHub on MSN
BioAffinity launches large-scale clinical study for lung cancer detection technology
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
Researchers evaluated four deep learning models using over 112,000 negative screening mammograms from the UK NHS to determine ...
Abstract: Medicine and healthcare have advanced significantly in the past four decades. We discovered the underlying causes of numerous illnesses at this time, produced efficient therapies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results